Edition:
India

Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

16.74USD
1:30am IST
Change (% chg)

$0.16 (+0.97%)
Prev Close
$16.58
Open
$16.75
Day's High
$17.01
Day's Low
$16.61
Volume
443,353
Avg. Vol
490,913
52-wk High
$49.87
52-wk Low
$11.50

About

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company’s product Rubraca (rucaparib), an oral small molecule inhibitor of poly adenosine diphosphate (ADP)-ribose polymerase (PARP), is... (more)

Overall

Beta: 1.61
Market Cap(Mil.): $4,124.93
Shares Outstanding(Mil.): 48.88
Dividend: --
Yield (%): --

Financials

Clovis Oncology halts mid-stage bladder cancer trial, shares drop

Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.

13 Apr 2019

Clovis Oncology halts mid-stage bladder cancer trial, shares drop

April 12 Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.

13 Apr 2019

Earnings vs. Estimates